You are here: Industry Insights > Bayer

News List

Bayer to Acquire KaNDy Therapeutics for $425M Upfront contractpharma
August 12, 2020
Expands women’s healthcare pipeline with Phase III-ready NT-814, a non-hormonal neurokinin-1,3 receptor antagonist for the treatment of menopause symptoms.
Bayer's finerenone hits targets in diabetes/kidney disease trial pharmatimes
July 14, 2020
Bayer's finerenone has hit key targets in a late-stage trial assessing its safety and efficacy in patients with chronic kidney disease (CKD) and type 2 diabetes.
Bayer close to glyphosate settlement worth $8-10 billion: German business daily expresspharma
June 24, 2020
The settlement is over claims that its glyphosate-based Roundup weedkiller causes cancer.
Bayer supports "The Challenge Initiative" of Johns Hopkins Bloomberg School of Public Health with 10 million USD worldpharmanews
June 22, 2020
Bayer announced the support of "The Challenge Initiative" with a payment of 10 million USD.
Bayer to support Harvard Research Study to Evaluate Trust in Science, Including in COVID-19 pandemic worldpharmanews
June 04, 2020
With the public debate on the merits of scientific data throughout the COVID-19 pandemic, Bayer announced its support for a new, multi-year Harvard Data Science Initiative (HDSI) research effort.
NICE issues final guidance on NHS use of Bayer's Vitrakvi pharmatimes
May 28, 2020
The National Institute for Health and Care Excellence (NICE) has published final guidance recommending NHS use of Bayer's Vitrakvi (larotrectinib) for a variety of cancers.
Bayer faces second investor reckoning over glyphosate litigation expresspharma
April 29, 2020
Criticism from investors at this year’s annual shareholders’ meeting – held in a virtual format with gatherings banned due to the coronavirus – will likely be less scathing than it was in 2019.
NICE backs NHS use of Bayer's Vitrakvi via the CDF pharmatimes
April 26, 2020
Bayer's Vitrakvi (larotrectinib) will be available via the NHS in England and Wales to treat a variety of cancers.
Bayer partners with Population Health Research Institute (PHRI) on global clinical research evaluating COVID-19 treatments worldpharmanews
April 26, 2020
Bayer announced its Canadian organization Bayer Inc., Mississauga, Ontario, will partner with the Population Health Research Institute (PHRI) in launching a major clinical research program aimed at identifying potential treatments against COVID-19.
Bayer partners with Population Health Research Institute on COVID-19 research pharmatimes
April 22, 2020
As of this morning – Wednesday April 22 – the current recorded case count for COVID-19 (coronavirus) in the UK has hit 129,044 with 17,337 deaths.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 20 21 Next page